vendredi 31 mars 2017

Medical News Today: Mesothelioma shows promising response to existing immunotherapy drug

Malignant pleural mesothelioma shows a promising response to treatment with the antibody drug pembrolizumab, which is used to treat other cancers. Medical News Today: Mesothelioma shows promising response to existing immunotherapy drug

Aucun commentaire:

Enregistrer un commentaire